FDA Approves POSILAC(R) Production at Monsanto's Augusta Facility
Posted on: Monday, 20 March 2006, 09:01 CST
ST. LOUIS, March 20 /PRNewswire-FirstCall/ -- Monsanto Company announced today that the U.S. Food and Drug Administration (FDA) has approved full production of POSILAC(R) bovine somatotropin (bST) at its manufacturing facility in Augusta, Georgia. POSILAC bST is used to enhance milk production and serves as an important tool to help dairy producers improve the efficiency and profitability of their operations.
"Full FDA approval of our Augusta facility is good news for U.S. dairy producers who choose to enhance the profitability of their operations with POSILAC bST," said Kevin Holloway, President of Monsanto's dairy business. "This additional production capacity will help us meet the full needs of our current customers. Once we can do that, we will begin to supply new customers with POSILAC bST."
With FDA approval of the Augusta plant complete, Monsanto is increasing production. "The Augusta plant will start making POSILAC bST for U.S. dairy producers immediately," said Deborah Small, Director of Manufacturing for Monsanto's dairy business. "POSILAC bST also is manufactured at an FDA-approved facility in Austria. FDA approval to formulate and package POSILAC bST at our Augusta plant allows production at both locations."
Monsanto employs over 200 people full-time at the Augusta facility, which is the largest pharmaceutical-grade protein manufacturing facility in the world. Construction of the plant was started in 1998 and the FDA approved the plant to produce the active ingredient in POSILAC bST in August 2003. Now the plant has full approval to formulate and package POSILAC bST for use by dairy producers.
Since it was first sold in 1994, POSILAC bST has become one of the leading dairy animal supplements in the United States. Supplementing dairy cows with POSILAC bST safely enhances milk production and serves as an important tool to help dairy producers improve the efficiency of their operations. Cows supplemented with POSILAC bST produce an average of 10 lb. more milk per day.
POSILAC bST can play a role in helping farmers with herds of all sizes produce more milk per cow. This provides dairy farmers with additional economic security by increasing the return on their investment.
About Monsanto
Monsanto Company is a leading provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see http://www.monsanto.com/ .
Note to editors: POSILAC is a trademark owned by Monsanto Company and its wholly owned subsidiaries.
Monsanto Company
CONTACT: Andrew Burchett for Monsanto Company, +1-314-694-4452
Web site: http://www.monsanto.com/
Company News On-Call: http://www.prnewswire.com/comp/114341.html
Source: PRNewswire-FirstCall
Related Articles
- Dairy Regulation Finds Favor among Consumers, Producers and Processors
- Rapid Growth of the Functional Dairy Sector - Read More Inside the Milk & Dairy Products Market Report 2007
- The Dairy Products Market in Western Europe is Forecast to Grow at an Average Annual Real 0.83% During the 2005 - 2010 Period
- The Dairy Products Market in China Increased in Value to Reach RMB85.50bn
- Produce Safety &Amp; Security International, Inc. Responds to FDA and Fresh Produce Industry's Concern Over the Presence of E. Coli H157
- Monsanto Gets Regulatory Approval for Hormone Production at Augusta, Ga., Plant
- Savannah Plant to Produce New Powerblend Beverage
- Don't Drop Milk and Dairy Products While Dieting
- Pfizer Plans to Close Augusta, Ga., Plant
- Garbage Power Plant to Produce Annual 100 Mln Kwh of Electricity in E. China City
 |
 |
User Comments (0)
RSS Feeds